1,055 results on '"Smedira, Nicholas G."'
Search Results
2. Efficacy and safety of a transaortic approach to midventricular and apical septal myectomy
3. Multifocal disease progression and subsequent intervention in patients with actin alpha-2 variants: A single-center experience
4. What determines outcomes in multivalve reoperations? Effect of patient and surgical complexity
5. Are there etiology-specific risk factors for adverse outcomes in patients on Impella 5.5 support?
6. Measurements of the Interventricular Septum and Mitral Leaflet Length in Hypertrophic Cardiomyopathy Patients Who Underwent Surgical Myectomy: A Prospective Comparative Multimodality Imaging Study
7. Increasing surgeon experience and cumulative institutional experience drive decreasing hospital mortality after reoperative cardiac surgery
8. Effects of mitral calcification in severe aortic stenosis with severe mitral regurgitation on left heart remodeling, surgical strategy, and outcomes
9. Re-repair of post–myocardial infarction ventricular septal rupture
10. Does Everyone Need High Technology Intervention Before They Die?
11. Multiarterial grafting in redo coronary artery bypass grafting: Type of arterial conduit and patient sex determine benefit
12. Patient reported outcomes in obstructive hypertrophic cardiomyopathy undergoing myectomy: Results from SPIRIT-HCM study
13. Public reporting for coronary artery bypass graft surgery: The quest for the optimal scorecard
14. Abstract 18270: Interagency Registry for Mechanically Assisted Circulatory Support Profile is Associated With Outcomes in Patients With an Impella 5.5 Ventricular Assist Device
15. Abstract 18247: Society for Cardiovascular Angiography and Intervention Shock Staging is Associated With Outcomes in Patients With an Impella 5.5 Temporary Left Ventricular Assist Device
16. Abstract 17216: Limited Concordance of Core Lab Left Ventricular Ejection Fraction With Automated Assessments: A Sub-Study From VALOR-HCM
17. Redefining “low risk”: Outcomes of surgical aortic valve replacement in low-risk patients in the transcatheter aortic valve replacement era
18. Modern practice and outcomes of reoperative cardiac surgery
19. Impact of Hospital Volume on Outcomes of Septal Myectomy for Hypertrophic Cardiomyopathy
20. Similar long-term survival after isolated bioprosthetic versus mechanical aortic valve replacement: A propensity-matched analysis
21. Ventricular Septal Myectomy for Obstructive Hypertrophic Cardiomyopathy (Analysis Spanning 60 Years Of Practice): AJC Expert Panel
22. Prognostic value of age-sex adjusted NT-proBNP ratio in obstructive hypertrophic cardiomyopathy
23. Risks and Outcomes of Reoperative Cardiac Surgery in Patients With Patent Bilateral Internal Thoracic Artery Grafts
24. Right Internal Thoracic Artery Patency Is Affected More by Target Choice Than Conduit Configuration
25. Mitral Leaflet Shortening: Less About Technique, More About Collaborative Teamwork.
26. Mitral Regurgitation in Obstructive Hypertrophic Cardiomyopathy
27. Outcomes after resection of primary cardiac sarcoma
28. 2021: The American Association for Thoracic Surgery Expert Consensus Document: Coronary artery bypass grafting in patients with ischemic cardiomyopathy and heart failure
29. Study design and rationale of VALOR-HCM: evaluation of mavacamten in adults with symptomatic obstructive hypertrophic cardiomyopathy who are eligible for septal reduction therapy
30. Characteristics and Longer-Term Outcomes of Contemporary Patients
31. Myosin Inhibition and Left Ventricular Diastolic Function in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy: Insights From the VALOR-HCM Study
32. Abstract 12598: Effect of Mavacamten on Systolic Anterior Motion of the Mitral Valve and Mitral Regurgitation in Patients With Obstructive Hypertrophic Cardiomyopathy: Insights From the VALOR-HCM Study
33. Abstract 12577: Effect of Mavacamten on Diastolic Function in Patients With Obstructive Hypertrophic Cardiomyopathy: Insights From the VALOR-HCM Study
34. Abstract 11324: Association of Patient Reported Outcomes With NYHA Class and Functional Capacity in Symptomatic Obstructive Hypertrophic Cardiomyopathy: An Analysis of Spirit-HCM Study
35. Surgical management of left ventricular outflow tract obstruction in a specialized hypertrophic obstructive cardiomyopathy center
36. Advances in managing the noninfected open chest after cardiac surgery: Negative-pressure wound therapy
37. Contemporary Surgical Management of Hypertrophic Cardiomyopathy in the United States
38. Multifocal Disease Progression and Subsequent Intervention in Patients with Actin Alpha-2 Variants; A Single Center Experience
39. What Determines Outcomes in Multivalve Reoperations? Effect of Patient and Surgical Complexity
40. Mavacamten in Patients With Hypertrophic Cardiomyopathy Referred for Septal Reduction
41. Prediction of sudden death risk in obstructive hypertrophic cardiomyopathy: Potential for refinement of current criteria
42. Increasing Surgeon Experience and Cumulative Institutional Experience Drive Decreasing Hospital Mortality after Reoperative Cardiac Surgery
43. Optimal Timing of Heart Transplant After HeartMate II Left Ventricular Assist Device Implantation
44. Comparison of Ventricular Septal Measurements in Hypertrophic Cardiomyopathy Patients Who Underwent Surgical Myectomy Using Multimodality Imaging and Implications for Diagnosis and Management
45. Abstract 15426: Comparison of Multimodality Imaging in Mitral Leaflet Lengths in Patients Undergoing Surgical Myectomy: A Prospective Study in Hypertrophic Obstructive Cardiomyopathy Patients
46. Abstract 13038: Utility of Left Atrial Strain Mechanics and Stiffness in Patients With Hypertrophic Cardiomyopathy
47. Long-term survival, valve durability, and reoperation for 4 aortic root procedures combined with ascending aorta replacement
48. Trends, Predictors, and Outcomes of Stroke After Surgical Aortic Valve Replacement in the United States
49. Different Histopathologic Diagnoses in Patients With Clinically Diagnosed Hypertrophic Cardiomyopathy After Surgical Myectomy
50. Dose-Blinded Myosin Inhibition in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy: Outcomes Through 32 Weeks
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.